{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:21:27Z","timestamp":1779891687690,"version":"3.53.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>For patients with primary brain injury, septic shock is especially dangerous due to the possibility of secondary cerebral damage. The key factor of sepsis-associated brain injury is inflammatory mediators, pathogen and damage-associated molecular patterns (PAMPs, DAMPs) release. Theoretically, blood purification may be beneficial for patients with primary brain injury due to its possibility for fast removal of inflammatory mediators.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report on six post-neurosurgery septic shock patients treated with combined blood purification (CBP), which included CRRT with high adsorption capacity membrane in combination with CytoSorb adsorber. Clinical improvement in the course of CBP was registered in all patients. Three patients had a stable clinical improvement; the other three patients had only a transient improvement due to underlying neurological and cardiac deficits aggravation. We observed septic shock reversal in four patients. The key observations of the case series are a significant decrease in MOF severity (measured by SOFA score) and in catecholamine need (not statistically significant). By the end of CBP we observed a significant decrease in blood lactate, PCT and IL-6 levels. Two patients demonstrated level of consciousness increase in the setting of CBP therapy measured by GCS and FOUR score.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This case series demonstrates that CBP therapy may have a role for septic shock patients with primary brain injury.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-021-00614-7","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T16:03:53Z","timestamp":1640016233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Observational case series: six neurosurgical patients with septic shock demonstrating clinical improvement after a combination of standard care and blood purification"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7909-2993","authenticated-orcid":false,"given":"A. I.","family":"Burov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9542-3801","authenticated-orcid":false,"given":"T. A.","family":"Abramov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8746-8727","authenticated-orcid":false,"given":"N. S.","family":"Kostritca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2204-4480","authenticated-orcid":false,"given":"D. S.","family":"Korotkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1442-5993","authenticated-orcid":false,"given":"G. V.","family":"Danilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5010-6661","authenticated-orcid":false,"given":"Y. V.","family":"Strunina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2594-5441","authenticated-orcid":false,"given":"I. A.","family":"Savin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"issue":"3","key":"614_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304\u201377.","journal-title":"Intensive Care Med"},{"issue":"2","key":"614_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/cc8856","volume":"14","author":"CS Burkhart","year":"2010","unstructured":"Burkhart CS, Siegemund M, Steiner LA. Cerebral perfusion in sepsis. Crit Care. 2010;14(2):215.","journal-title":"Crit Care"},{"issue":"3","key":"614_CR3","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s12035-017-0526-2","volume":"55","author":"B Bellaver","year":"2018","unstructured":"Bellaver B, et al. Systemic inflammation as a driver of brain injury: the astrocyte as an emerging player. Mol Neurobiol. 2018;55(3):2685\u201395.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"614_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1590\/1516-4446-2013-1233","volume":"36","author":"F Dal-Pizzol","year":"2014","unstructured":"Dal-Pizzol F, Tomasi CD, Ritter C. Septic encephalopathy: does inflammation drive the brain crazy? Braz J Psychiatry. 2014;36(3):251\u20138.","journal-title":"Braz J Psychiatry"},{"issue":"4","key":"614_CR5","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.V104846","volume":"10","author":"AS De Vriese","year":"1999","unstructured":"De Vriese AS, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol. 1999;10(4):846\u201353.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"614_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5301\/ijao.5000492","volume":"39","author":"K Trager","year":"2016","unstructured":"Trager K, et al. Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series. Int J Artif Organs. 2016;39(3):141\u20136.","journal-title":"Int J Artif Organs"},{"issue":"1","key":"614_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s13054-019-2588-1","volume":"23","author":"WP Brouwer","year":"2019","unstructured":"Brouwer WP, et al. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study. Crit Care. 2019;23(1):317.","journal-title":"Crit Care"},{"issue":"1","key":"614_CR8","doi-asserted-by":"publisher","first-page":"13995","DOI":"10.1038\/s41598-018-32275-8","volume":"8","author":"H Matsumoto","year":"2018","unstructured":"Matsumoto H, et al. The clinical importance of a cytokine network in the acute phase of sepsis. Sci Rep. 2018;8(1):13995.","journal-title":"Sci Rep"},{"issue":"1","key":"614_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13054-019-2399-4","volume":"23","author":"EC Poli","year":"2019","unstructured":"Poli EC, et al. Cytokine clearance with CytoSorb\u00ae during cardiac surgery: a pilot randomized controlled trial. Crit Care. 2019;23(1):108.","journal-title":"Crit Care"},{"issue":"1","key":"614_CR10","doi-asserted-by":"publisher","first-page":"e0191676","DOI":"10.1371\/journal.pone.0191676","volume":"13","author":"MC Gruda","year":"2018","unstructured":"Gruda MC et al. Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb\u00ae sorbent porous polymer beads. PLoS ONE. 2018;13(1):e0191676.","journal-title":"PLoS ONE"},{"issue":"4","key":"614_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000492379","volume":"46","author":"A Bonavia","year":"2018","unstructured":"Bonavia A, et al. Clinical utility of extracorporeal cytokine hemoadsorption therapy: a literature review. Blood Purif. 2018;46(4):337\u201349.","journal-title":"Blood Purif"},{"key":"614_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40560-017-0208-1","volume":"5","author":"S David","year":"2017","unstructured":"David S, et al. Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient. J Intensive Care. 2017;5:12.","journal-title":"J Intensive Care"},{"issue":"2\u20133","key":"614_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2478\/prilozi-2018-0039","volume":"39","author":"T Matsui","year":"2018","unstructured":"Matsui T, et al. The effect of continuous renal replacement therapy with the AN69ST membrane on inflammatory markers and the level of consciousness of hemodialysis patients with stroke: comparison with hemodialysis with low blood flow rate. Prilozi. 2018;39(2\u20133):29.","journal-title":"Prilozi"},{"issue":"4","key":"614_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10047-016-0915-8","volume":"19","author":"NJ Lees","year":"2016","unstructured":"Lees NJ, et al. Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to Panton-Valentine leukocidin-positive Staphylococcus aureus pneumonia and H1N1. J Artif Organs. 2016;19(4):399\u2013402.","journal-title":"J Artif Organs"},{"issue":"3","key":"614_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10047-017-0967-4","volume":"20","author":"S Friesecke","year":"2017","unstructured":"Friesecke S, et al. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study. J Artif Organs. 2017;20(3):252\u20139.","journal-title":"J Artif Organs"},{"issue":"8","key":"614_CR16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00063-017-0342-5","volume":"114","author":"S Friesecke","year":"2019","unstructured":"Friesecke S, et al. International registry on the use of the CytoSorb(R) adsorber in ICU patients: study protocol and preliminary results. Med Klin Intensivmed Notfmed. 2019;114(8):699\u2013707.","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"5","key":"614_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.5301\/ijao.5000315","volume":"37","author":"H Hetz","year":"2014","unstructured":"Hetz H, et al. Septic shock secondary to beta-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int J Artif Organs. 2014;37(5):422\u20136.","journal-title":"Int J Artif Organs"},{"issue":"5\u20136","key":"614_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1159\/000111568","volume":"25","author":"Y Kobe","year":"2007","unstructured":"Kobe Y, et al. Direct hemoperfusion with a cytokine-adsorbing device for the treatment of persistent or severe hypercytokinemia: a pilot study. Blood Purif. 2007;25(5\u20136):446\u201353.","journal-title":"Blood Purif"},{"issue":"7","key":"614_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/1756-0500-7-458","volume":"17","author":"S Jain","year":"2014","unstructured":"Jain S, Sinha S, Sharma SK, Samantaray JC, Aggrawal P, Vikram NK, Biswas A, Sood S, Goel M, Das M, Vishnubhatla S, Khan N. Procalcitonin as a prognostic marker for sepsis: a prospective observational study. BMC Res Notes. 2014;17(7):458.","journal-title":"BMC Res Notes"},{"key":"614_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcrc.2018.11.003","volume":"49","author":"F Hawchar","year":"2019","unstructured":"Hawchar F, et al. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study. J Crit Care. 2019;49:172\u20138.","journal-title":"J Crit Care"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-021-00614-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-021-00614-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-021-00614-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T16:06:28Z","timestamp":1640016388000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-021-00614-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1186\/s40001-021-00614-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"28 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}